With a focus on determining how cancer treatments are working, AIQ Solutions offers a medical software platform designed to provide unique intelligence about oncology treatment effectiveness and toxicity risk. With close ties to University of Wisconsin's WARF, the AI developed platform analyzes longitudinal patient data to evaluate treatment response heterogeneity. AIQ is structured to quantify and characterize treatment response for each individual lesion and organ system. With this intelligence, AIQ software can make early predictions of treatment effectiveness and toxicity risk. Pharma and biotech companies are using AIQs technology in early stage studies better to understand pharmacodynamic effects, toxicity risk, and mechanisms of resistance. Hospital systems use AIQ's technology to make real-time adjustments to patient therapy. In 2018, AIQ received FDA clearance to begin marketing its first product - Quantitative Total Bone Imaging.
